Ballicules.com

Methazolamide

NEPTAZANE

What it isCarbonic anhydrase inhibitor; glaucoma.

Why this oneIt has less renal effect and is often better tolerated than acetazolamide at equivalent pressure reduction.

What limits itParesthesia, fatigue and metabolic acidosis persist; it is a sulfonamide.

FDA-approved for

FDA label

FDA dosingPopulationStartTargetMax
Glaucoma (elevated intraocular pressure)adult50 mg BID-TID50-100 mg BID-TID100 mg TID

Renal Contraindicated in marked kidney disease or dysfunction

Hepatic Contraindicated in marked liver disease/dysfunction; may precipitate hepatic encephalopathy in cirrhosis

Instructions

Contraindications

Cautions

Adverse reactions

Pregnancy Category C; teratogenic (skeletal anomalies) in rats; use only if benefit justifies fetal risk

Lactation Undefined

NO BOXED WARNINGS

Principal riskParaesthesia and metabolic acidosis

Cost, est. cash$10–$400/month

Generic entry1993

Classes and tags

Clinical profile

Therapeutic safety burden1 / 4
Overdose danger1 / 4
Weight-gain liability0 / 4
Sedation liability0 / 4
QT / Torsades0 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk1 / 4

Legacy pregnancy categoryUnknown / historical label unavailable

Defining liabilityGenerally tolerated at therapeutic doses; clinically important risks are agent-specific and increase with interactions or organ impairment.

Mechanism of action: Methazolamide ballicule

Methazolamide ballicule: receptor binding, kinetics and half-life diagram

Open Methazolamide in the interactive console ↗

Memory aids: mascots and interaction avatars

Methazolamide NEPTAZANE mascot mnemonic cartoon
“Neptune Zane’s Meat hazard”
carbonated soda → carbonic anhydrase inhibitor
Methazolamide urinary alkalinizer avatar
urinary alkalinizer

Open Methazolamide in the interactive console ↗